scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1006517417 |
P356 | DOI | 10.1007/S10549-010-0745-Y |
P698 | PubMed publication ID | 20135348 |
P5875 | ResearchGate publication ID | 41410165 |
P50 | author | Michal Zikán | Q41347017 |
Zdeněk Kleibl | Q43299807 | ||
Jaroslav Kotlas | Q43638996 | ||
Ivana Tichá | Q43639012 | ||
Martina Zimovjanova | Q43639029 | ||
Martin Matějů | Q59060827 | ||
P2093 | author name string | Petr Pohlreich | |
Jana Stribrna | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ovarian cancer | Q172341 |
P304 | page(s) | 337-347 | |
P577 | publication date | 2010-02-05 | |
P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
P1476 | title | Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene | |
P478 | volume | 124 |
Q42181679 | A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer |
Q37089839 | A novel deleterious c.2656G>T MSH2 germline mutation in a Pakistani family with a phenotypic overlap of hereditary breast and ovarian cancer and Lynch syndrome |
Q57949646 | Alu elements mediate large SPG11 gene rearrangements: further spatacsin mutations |
Q43989797 | Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer |
Q42379886 | Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family |
Q37995560 | Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin |
Q35029565 | Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry |
Q92377028 | Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers |
Q50476179 | Familial breast cancer genetic testing in the West of Ireland. |
Q36117690 | Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control |
Q36841814 | Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint |
Q37593704 | Genomic rearrangement screening of the BRCA1 from seventy Iranian high-risk breast cancer families. |
Q57728244 | Haplotype analysis of two recurrent genomic rearrangements in the BRCA1 gene suggests they are founder mutations for the Greek population |
Q43437825 | Large BRCA1 and BRCA2 genomic rearrangements in Polish high-risk breast and ovarian cancer families |
Q35600785 | New recurrent BRCA1/2 mutations in Polish patients with familial breast/ovarian cancer detected by next generation sequencing |
Q53427698 | Occurrence of a non deleterious gene conversion event in the BRCA1 gene. |
Q44820973 | Prevalence and differentiation of hereditary breast and ovarian cancers in Japan |
Q41694365 | Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice |
Q52591829 | Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes. |
Search more.